Unit I KANDLA, GUJARAT Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Tablets

10 Million

Coated Tablets

1 Million

 General Capsules

788 Million

β-Lactum Capsules

613 Million

Sachet

221 Million

β-Lactum dry Syrup

26 Million

Vials

53 Million

Glass Ampoule

48 Million

Plastic Ampoule

1.5 Million

Cream & Ointment

11 Millions

Approved by

  • WHO (India)
  • South Africa(MCC/SAHPRA)
  • Industry and Trade of the Russian Federation
  • Kenya - PPB
  • United Arab Emirates Ministry of Health and Prevention
  • Medicine Control Authority of Zimbabwe
  • ISO (ISO 13485:2016/NS-EN ISO 13485:2016)
  • ANVISA-BRAZIL
  • Tanzania
  • Zimbabwe
  • State GMP
  • UAE-MOH

Planned by:

  • EU
  • CANADA
  • EAEU
  • PIC/S (Ukraine )
  • Kenya
  • Uganda
  • Mexico

Unit II KANDLA, GUJARAT Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Transdermal Patches

10.8 Million

GMP certification

  • ANVISA-BRAZIL
  • TGA
  • UAE-MOH
  • National Drug Authority
  • WHO (India)
  • State GMP

Planned by:

  • EU
  • Russia

DEHRADUN, UTTARAKHAND Formulation Facility

Facility Capabilities

Dosage form

Units/Annum

Tablets

4300 Million

Capsules

21 Million

Sachet

21 Million

Transdermal Patches 

8.64 Million

Granules

4000 kg

Vials

40 Million

Bottles

0.1 Million

Ampoule

90 Million

Pre Filled Syring

15 Million

Syrup

9.36 Millions Bottles

Approved by

  • EU (Belgium)
  • HEALTH CANADA
  • TGA
  • ANVISA
  • UAE-MOH
  • Ukraine – PIC/S
  • South Africa(MCC/SAHPRA)
  • WHO (India)
  • Uganda
  • Arab Emirates
  • ISO (ISO 13485:2016/NS-EN ISO 13485:2016)
  • Tanzania - TFDA
  • IDA
  • Namibia
  • GMP

Planned by:

  • UK
  • Russia
  • Switzerland
  • Malaysia
  • Philippines
  • Kenya

PITHAMPUR,MADHYA PRADESHAPI Facility II

Planned by:

  • USFDA
  • EUGMP
  • WHO (India)
  • State GMP

Ankleshwar, GUJARAT API Facility I

Facility Capabilities

Production

Capacity (KL)

Plant – I

13.0KL

Plant – II

15.5KL

Total

28.5 KL (32Tons ) of annual production

API Manufacturing facility is Approved by:

  • BRAZIL
  • HEALTH CANADA
  • EDQM - EUROUPE
  • EU (Belgium)
  • FAMHP- Belgium
  • WHO (India)
  • State GMP

Planned by:

  • USFDA

Business Enquiries and Contact Information